Monogram Orthopaedics Inc... (MGRM)
Bid | 2.35 |
Market Cap | 87.61M |
Revenue (ttm) | n/a |
Net Income (ttm) | -16.01M |
EPS (ttm) | -0.5 |
PE Ratio (ttm) | -4.91 |
Forward PE | -5.83 |
Analyst | Strong Buy |
Ask | 2.61 |
Volume | 23,923 |
Avg. Volume (20D) | 658,536 |
Open | 2.47 |
Previous Close | 2.44 |
Day's Range | 2.42 - 2.48 |
52-Week Range | 1.92 - 4.21 |
Beta | 0.41 |
About MGRM
undefined
Analyst Forecast
According to 0 analyst ratings, the average rating for MGRM stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts
3 weeks ago · seekingalpha.com
Monogram Technologies Inc. (MGRM) Q1 2025 Earnings Call TranscriptMonogram Technologies Inc. (NASDAQ:MGRM ) Q1 2025 Earnings Conference Call May 14, 2025 4:30 PM ET Company Participants Larry Holub - Investor Relations Noel Knape - Chief Financial Officer Ben Sexson...

2 months ago · accessnewswire.com
Monogram Technologies Partners with Urvin to Launch an Exclusive, Verified Shareholder CommunityAUSTIN, TX / ACCESS Newswire / March 20, 2025 / Monogram Technologies Inc. (NASDAQ:MGRM) ("Monogram" or the "Company"), an AI-driven robotics company focused on improving human health with an initial ...

2 months ago · accessnewswire.com
Monogram Technologies Announces FDA 510(k) Clearance for the Monogram mBôsTM TKA SystemMonogram May Market the Monogram mBôs™ TKA System, Subject to the Requirements of the Federal Food, Drug, and Cosmetic Act (the Act). The Company is Preparing for Commercialization and Evaluating Stra...

2 months ago · seekingalpha.com
Monogram Technologies Inc. (MGRM) Q4 2024 Earnings Call TranscriptMonogram Technologies Inc. (NASDAQ:MGRM ) Q4 2024 Earnings Conference Call March 11, 2025 4:30 PM ET Company Participants Larry Holub - Investor Relations Benjamin Sexson - Chief Executive Officer Noe...

2 months ago · accessnewswire.com
CORRECTION: Monogram Technologies Reports Full Year 2024 Financial ResultsThis Press Release is Acting as a Correction to the Financial Tables in the Previous Release Completed all Supplemental Testing and has Submitted its Formal Response to the FDA's Additional Informatio...

2 months ago · accessnewswire.com
Monogram Technologies Reports Full Year 2024 Financial ResultsCompleted all Supplemental Testing and has Submitted its Formal Response to the FDA's Additional Information Request (AIR) Management to Host Business Update Conference Call on Wednesday, March 12, 20...